BioMarin Pharmaceutical Inc. (BMRN) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

BioMarin Pharmaceutical I...

NASDAQ: BMRN · Real-Time Price · USD
57.55
0.80 (1.41%)
At close: Sep 05, 2025, 3:41 PM

BioMarin Pharmaceutical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
426.86M 167.65M 141.56M -64.08M
Depreciation & Amortization
96.43M 104.39M 101.97M 108.04M
Stock-Based Compensation
201.57M 207.1M 196.31M 197.26M
Other Working Capital
-62.72M -57.9M -5.1M 19.83M
Other Non-Cash Items
8.29M 61.65M -115.47M 12.89M
Deferred Income Tax
56.1M -44.98M -52.09M -15.61M
Change in Working Capital
-216.4M -336.54M -96.38M 66.03M
Operating Cash Flow
572.84M 159.26M 175.9M 304.54M
Capital Expenditures
-97.42M -107.61M -131.54M -119.22M
Cash Acquisitions
n/a n/a n/a -23.65M
Purchase of Investments
-410.25M -868.5M -611.81M -937.14M
Sales Maturities Of Investments
633.02M 864.86M 620M 691.05M
Other Investing Acitivies
-853K -10.92M 103.33M 22.65M
Investing Cash Flow
136.49M -111.24M -20.03M -366.31M
Debt Repayment
-494.99M -2.29M -2.6M -3.04M
Common Stock Repurchased
n/a -76.32M -54.28M -45.8M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-80.74M -85.79M -85.38M -46.2M
Financial Cash Flow
-526.45M -18.73M -18.65M -48K
Net Cash Flow
187.72M 30.6M 137.25M -61.88M
Free Cash Flow
475.42M 51.65M 44.36M 185.31M